Please enable JavaScript to use this page!

Ipsen Pediatric Endocrinology

Client

IPSEN PHARMA

Therapeutical Area

Pediatric Endocrinology

Brief

Ipsen European Pediatric Endocrinology has a unique portfolio that covers the continuum of defects in the GH-IGF axis and the treatment of precocious puberty: Nutropin Aq® for growth disorders, Increlex® for severe IGF-1 deficiency and Decapeptyl® for central precocious puberty.

We built a strategy for the Business Unit, which goals were to build strong relationships that will truly bring benefits to the patients, value to clinicians and to the whole pediatric endocrinology community.

“Engaging in growth”: together we build the future of pediatric endocrinology.

We did

Strategy // Creativity // Audiovisual // Digital // Events

ipsen-logo